AQR Arbitrage LLC - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 45 filers reported holding BIOPLUS ACQUISITION CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AQR Arbitrage LLC ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$16,493
-62.0%
294,5250.0%0.00%
-50.0%
Q2 2023$43,413
+53.8%
294,525
-0.8%
0.00%
+100.0%
Q1 2023$28,219
-9.5%
297,039
-4.8%
0.00%0.0%
Q4 2022$31,167
+24.7%
311,9770.0%0.00%0.0%
Q3 2022$25,000
-43.2%
311,9770.0%0.00%0.0%
Q2 2022$44,000
-36.2%
311,9770.0%0.00%
-50.0%
Q1 2022$69,000311,9770.00%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Atalaya Capital Management LP 125,000$7,5000.01%
Q Global Advisors, LLC 195,489$110.01%
MMCAP International Inc. SPC 325,000$18,2000.01%
PERISCOPE CAPITAL INC. 867,072$48,5560.01%
MARSHALL WACE, LLP 78,611$2,543,0660.01%
HGC Investment Management Inc. 200,000$11,2000.00%
Spartan Fund Management Inc. 75,000$4,2000.00%
EHP Funds Inc. 125,186$7,0100.00%
COWEN AND COMPANY, LLC 522,096$29,2370.00%
Radcliffe Capital Management, L.P. 200,049$13,9430.00%
View complete list of BIOPLUS ACQUISITION CORP shareholders